Department of Hepatology and Liver Transplant, Institute of Liver and Biliary Sciences, D-1, VasantKunj, New Delhi, 110070, India.
Hepatol Int. 2018 Sep;12(5):402-416. doi: 10.1007/s12072-018-9887-5. Epub 2018 Aug 16.
Acute-on-chronic liver failure (ACLF) is a distinct syndrome of liver failure in a patient with chronic liver disease presenting with jaundice, coagulopathy and ascites and/or hepatic encephalopathy, developing following an acute hepatic insult and associated with high 28-day mortality. The definition though lacks global consensus, excludes patients with known distinct entities such as acute liver failure and those with end-stage liver disease. The initial Systemic Inflammatory Response Syndrome (SIRS) because of cytokine storm in relation to acute insult and/or subsequent development of sepsis due to immunoparalysis leads to extrahepatic organ failure. These cascades of events progress through a 'Golden Window' period of about 7 days, subsequent to which majority of the patients develop complications, such as sepsis and extrahepatic organ failure. Prevention of sepsis, support of organs and management of organ failure (commonly hepatic, renal, cerebral, coagulation) and early referral for transplant is crucial. The APASL ACLF research consortium (AARC) liver failure score is a dynamic prognostic model for management decisions and is superior to existing models. Aggressive multidisciplinary approach can lead to a transplant-free survival in nearly half of the cases. The present review provides an algorithmic approach to management of organ failure, sepsis prevention, use of dynamic prognostic models for management decision and is aimed to improve the skills for managing and improving the outcomes of such critically ill patients.
急性肝衰竭(ACLF)是一种慢性肝病患者中发生的肝衰竭综合征,其特征为黄疸、凝血障碍和腹水和/或肝性脑病,在急性肝损伤后发生,并伴有高 28 天死亡率。尽管该定义缺乏全球共识,但它排除了具有明确实体的患者,如急性肝衰竭和终末期肝病患者。由于与急性损伤相关的细胞因子风暴和随后由于免疫麻痹导致的败血症,最初的全身炎症反应综合征(SIRS)导致肝外器官衰竭。这些事件通过大约 7 天的“黄金窗口期”进展,此后大多数患者会出现并发症,如败血症和肝外器官衰竭。预防败血症、支持器官和管理器官衰竭(通常是肝、肾、脑、凝血)以及早期转介进行移植至关重要。APASL ACLF 研究联盟(AARC)肝衰竭评分是一种用于管理决策的动态预后模型,优于现有模型。积极的多学科方法可以使近一半的患者在没有移植的情况下存活。本综述提供了一种针对器官衰竭管理、预防败血症、使用动态预后模型进行管理决策的算法方法,旨在提高管理和改善此类重症患者结局的技能。